ATF3 and ovarian carcinoma: Studies showed that activating transcription factor 3 (ATF3), MYC proto-oncogene, and bHLH transcription factor were potential cotargets of miR-30 family, which present as regulators in the different pathways in numerous human cancers.[14] The OncoLnc dataset showed that only elevated expression of miR-30d-5p associated with better OS, which suggesting the potentiality of miR-30d to be used as prognostic biomarker for ovarian cancer.